Aventis Sues Sandoz Over Generic Taxotere

Law360, New York (January 13, 2011, 1:39 PM EST) -- Aventis Pharma SA and Sanofi-Aventis US LLC have filed a patent infringement suit seeking to block Sandoz Inc.'s efforts to market a generic version of cancer treatment Taxotere.

Aventis filed the lawsuit in the U.S. District Court for the District of Delaware on Wednesday, asserting two patents that the Delaware court found to be invalid in September in a related case Aventis brought against Hospira Inc. and Apotex Inc. that is currently on appeal.

Sanofi-Aventis US holds an approved new drug application for Taxotere's active ingredient,...
To view the full article, register now.